To analyze the mechanism of drug-induced liver failure by using iPS cells

To analyze the mechanism of drug-induced liver failure by using iPS cells - Analysis of drug-induced liver failure

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016354

Enrollment

Registered

2015-02-15

Start date

2015-02-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with drug-induced liver failure

Interventions

To use blood cells and/or skin from patients with drug-induced liver failure

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with drug-induced liver failure

Exclusion criteria

Exclusion criteria: 1 Patients with bleeding tendency 2 Patients with non-concurrence

Design outcomes

Primary

Measure	Time frame
To clarity the mechanism of drug-induced liver-failure by using hepatocyte from human iPS cells, PBMCs and suspected drugs.	—

Countries

Japan

Contacts

Public ContactGoki Suda

Graduate School of Medicine, Hokkaido University Department of Gastroenterology and Hepatology

gsudgast@pop.med.hokudai.ac.jp011-716-1161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026